Next Article in Journal
Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease
Next Article in Special Issue
Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging
Previous Article in Journal
Individual Treatment Trials—Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis?
Previous Article in Special Issue
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(3), 417; https://doi.org/10.3390/ph16030417
Action Date Notes Link
article xml file uploaded 9 March 2023 11:44 CET Original file -
article xml uploaded. 9 March 2023 11:44 CET Update https://www.mdpi.com/1424-8247/16/3/417/xml
article pdf uploaded. 9 March 2023 11:44 CET Version of Record https://www.mdpi.com/1424-8247/16/3/417/pdf
article supplementary file uploaded. 9 March 2023 11:44 CET - https://www.mdpi.com/1424-8247/16/3/417#supplementary
article html file updated 9 March 2023 11:46 CET Original file -
article html file updated 20 March 2023 22:00 CET Update https://www.mdpi.com/1424-8247/16/3/417/html
Back to TopTop